Magnetoencephalography (MEG) and Magnetic Source Imaging (MSI)
The Neurologist 10:138-153, Wheless,J.W.,et al, 2004
Cerebral Hemispherectomy
Neurol 62:1712-1721,1664, Jonas,R.,et al, 2004
Calcific Neurocysticercosis and Epileptogenesis
Neurol 62:1934-1938, Nash,T.E.,et al, 2004
Levetiracetam in the Treatment of Idiopathic Hemifacial Spasm
Neurol 62:2134-2135, Deleu,D., 2004
Marijuana Use and Epilepsy
Neurol 62:2095-2097, Gross,D.W.,et al, 2004
Neurosyphilis with Complex Partial Status Epilepticus and Mesiotemporal MRI Abnormalities Mimicking herpes Simplex Encephalitis
JNNP 75:833, Marano,E.,et al, 2004
Flavivirus Encephalitis
NEJM 351:370-378, Solomon,T., 2004
MMR Vaccination and Febrile Seizures
JAMA 292:351-357, Vestergaard,M.,et al, 2004
Ictal Stuttering
Neurol 63:516-519, Vossler,D.G.,et al, 2004
The Neurological Complications of Bariatric Surgery
Arch Neurol 61:1185-1189, Berger,J.R., 2004
Seizure Outcomes After Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations
Neurol 63:683-687, Schauble,B.,et al, 2004
Monotherapy in Epilepsy
Arch Neurol 61:1361-1365, Vazquez,B., 2004
Diffusion-Weighted and Conventional MR Imaging Findings of Neuroaxonal Dystrophy
AJNR 25:1269-1273, Sener,R.N., 2004
Clinicopath Conf, Anaplastic Oligodendroglioma with Allelic Loss of Chromosomes 1p and 19q
NEJM 351:1875-1882, Case 33-2004, 2004
Rapid Infusion with Valproate Sodium is Well Tolerated in Patients with Epilepsy
Neurol 63:1507-1508, Wheless,J.W.,et al, 2004
Lower Phenytoin Serum Levels in Persons Switched from Brand to Generic Phenytoin
Neurol 63:1494-1496, Burkhardt,R.T.,et al, 2004
Mortality in Epilepsy: Driving Fatalities vs Other Causes of Death in Patients with Epilepsy
Neurol 63:1002-1007, Sheth,S.G.,et al, 2004
Post-Stroke Movement Disorders; Report of 56 Patients
JNNP 75:1568-1574, Alarcon,F.,et al, 2004
Neonatal Brain Injury
NEJM 351:1985-1995, Ferriero,D.M., 2004
Injuries Due to Seizures in Persons with Epilepsy
Neurol 63:1565-1570, Lawn,N.D.,et al, 2004
The United Kingdom Infantile Spasms Study Comparing Vigabatrin with Prednisolone or Tetracosactide at 14 Days: A Multicentre, Randomised Controlled Trial
Lancet 364:1773-1778, Lux,A.L.,et al, 2004
Clinically Mild Encephalitis Encephalopathy with a Reversible Splenial Lesion
Neurol 63:1854-1858, Tada,H.,et al, 2004
Epileptic Seizures in Systemic Lupus Erythematosus
Neurol 63:1808-1812, Appenzeller,S.,et al, 2004
Natural History of Nonketotic Hyperglycinemia in 65 Patients
Neurol 63:1847-1853, Hoover-Fong,J.E.,et al, 2004
MR Spectroscopy in the Diagnosis of Cerebral Amyloid Angiopathy Presenting as a Brain Tumor
AJNR 25:1705-1708, Safriel,Y.,et al, 2004
Parenchymal Abnormalities Associated with Cerebral Venous Sinus Thrombosis: Assessment with Diffusion-Weighted MR Imaging
AJNR 25:1666-1675, Mullins,M.E.,et al, 2004
Normal Intelligence in Children with Prenatal Exposure to Carbamazepine
Neurol 62:28-32,8, Gaily,E.,et al, 2004
Systematic Screening Allows Reduction of Adverse Antiepileptic Drug Effects
Neurol 62:23-27, Gilliam,F.G.,et al, 2004
Tapeworms and Seizures--Treatment and Prevention
NEJM 350:215-217, Maguire,J.H., 2004
A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis
NEJM 350:249-258,215,280, Garcia,H.H.,et al, 2004
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
The New Antiepileptic Drugs, Clinical Applications
JAMA 291:615-620, LaRoche,S.M.&Helmers,S.L., 2004
Epilepsy
JAMA 291:654, Parmet,S, 2004
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Lateralizing Value of Todd's Palsy in Patients with Epilepsy
Neurol 62:289-291, Kellinghaus,C.&Kotagal,P., 2004
Postpartum Angiopathy with Reversible Posterior Leukoencephalopathy
Arch Neurol 61:411-416, Singhal,A.B., 2004
Cognitive Side Effects of Antiepileptic Drugs in Children
Neurol 62:872-877, Loring,D.W.&Meador,K.J., 2004
The AED (Antiepileptic Drug) Pregnancy Registry
Arch Neurol 61:673-678, Holmes,L.B.,et al, 2004
Meningiomas
Lancet 363:1535-1543, Whittle,I.R.,et al, 2004
Efficacy and Tolerability for the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
Neurol 62:1252-1260, French,J.A.,et al, 2004
Efficacy and Tolerability of the New Antiepleptic Drugs II: Treatment of Refractory Epilepsy
Neurol 62:1261-1273, French,J.A.,et al, 2004
Reversible Parkinsonism with Normal B-CIT-SPECT in Patients Exposed to Sodium Valproate
Neurol 62:1435-1437, Easterford,K.,et al, 2004
Valproate Therapy and Nonalcoholic Fatty Liver Disease
Ann Neurol 55:729-732, Luef,G.J.,et al, 2004
Late-Onset Seizures as a Predictor of Subsequent Stroke
Lancet 363:1184-1186,1175, Cleary,P.,et al, 2004
Clinical Manifestations of Cerebral Amyloid Angiopathy-Related Inflammation
Ann Neurol 55:250-256, Eng,J.A.,et al, 2004
Potassium Channel Antibody-Associated Encephalopathy: A Potentially Immunotherapy-Responsive Form of Limbic Encepahlitis
Brain 127:701-712, Vincent,A.,et al, 2004
Potentially Reversible Autoimmune Limbic ncephalitis with Neuronal Potassium Channel Antibody
Neurol 62:1177-1182,1040, Thieben,M.J.,et al, 2004
Trigeminal Neuralgia and Glossopharyngeal Neuralgia
Neurol Clin N Am 22:185-206, Rozen,T.D., 2004
Clinical Correlations of Mutations in the SCN1A Gene: From Febrile Seizures to Severe Myoclonic Epilepsy in Infancy
Pediatr Neurol 30:236-243, Ceulemans,B.P.G.M.,et al, 2004
Imaging Manifestations of Neurosarcoidosis
AJR 182:289-295, Smith, J.K.,et al, 2004